Skip to main content
SpringerLink
Log in

Assessing the Cost-effectiveness of Alternative Approaches to HIV Prevention

  • Chapter
Beyond Condoms

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abramson, P.R. & Pinkerton, S.D. (1995). With Pleasure: Thoughts on the Nature of Human Sexuality. New York: Oxford University Press.

    Google Scholar 

  • Anonymous (1993). The female condom. Medical Letter on Drugs and Therapeutics, 35, 123–124.

    Google Scholar 

  • Bedimo, A.L., Pinkerton, S.D., Cohen, D.A., Gray, B., & Farley, T.A. (under review). Cost-effectiveness of a condom social marketing program. Journal of the American Medical Association.

    Google Scholar 

  • Bloom, D.E. & Carliner, G. (1988). The economic impact of AIDS in the United States. Science, 239, 604–610.

    PubMed  CAS  Google Scholar 

  • Byrn, R.A., Zhang, D., Eyre, R., McGowan, K., & Kiessling, A.A. (1997). HIV-1 in semen: An isolated virus reservoir. Lancet, 350, 1141.

    Article  PubMed  CAS  Google Scholar 

  • Cardo, D.M., Culver, D.H., Ciesielski C.A., Srivastava, P.U., Marcus, R., Abiteboul, D., Heptonstall, J., Ippolito, G., Lot, F., McKibben, P.S., Bell, D.M., and the Centers for Disease Control and Prevention Needlestick Surveillance Group (1997). A case-control study of HIV seroconversion in health care workers after percutaneous exposure. New England Journal of Medicine, 337, 1485–1490.

    Article  PubMed  CAS  Google Scholar 

  • Cecil, H., Perry, M.J., Seal, D.W., & Pinkerton, S.D. (1998). The female condom: What we have learned thus far. AIDS and Behavior, 2, 241–256.

    Article  Google Scholar 

  • Centers for Disease Control (1990). Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding post-exposure use. Morbidity and Mortality Weekly Report, 39 (no. RR-1).

    Google Scholar 

  • Centers for Disease Control (1993). Supplemental guidance on HIV prevention community planning for noncompeting continuation of cooperative agreements for HIV prevention projects. Atlanta, GA: Centers for Disease Control.

    Google Scholar 

  • Centers for Disease Control (1995). Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood — France, United Kingdom, and United States, January 1988–August 1994. Morbidity and Mortality Weekly Report, 44, 929–933.

    Google Scholar 

  • Centers for Disease Control (1996). Update: Provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. Morbidity and Mortality Weekly Report, 45, 468–472.

    Google Scholar 

  • Chesson, H.W. & Pinkerton, S.D. (under review). STDs and the increased risk for HIV transmission: Implications for cost-effectiveness analyses of STD prevention interventions. Journal of Acquired Immune Deficiency Syndromes.

    Google Scholar 

  • Chesson, H.W., Pinkerton, S.D., Rein, D., Kassler, W.J., & Irwin, K.L. (1999). New HIV cases attributable to syphilis in the United States: Estimates from a simplified transmission model. AIDS, 13, 1387–1396.

    PubMed  CAS  Google Scholar 

  • Chirianni, A., Perna, E., Liuzzi, G., D’Abbraccio, M., Bonadies, G., Paone, G., Foggia, M., Patricelli, V., & Piazza, M. (1992). Absence of anti-HIV seroconversion in heterosexual partners of HIV patients treated with zidovudine. International Conference on AIDS (abstract no. PoC 4530), June 19–24.

    Google Scholar 

  • Clemmer, B. & Haddix, A.C. (1996). Cost-benefit analysis. In A.C. Haddix, S.M. Teutsch, P.A. Shaffer, D.O. Duñet (eds.), Prevention effectiveness: A guide to decision analysis and economic evaluation. New York: Oxford University Press; 85–102.

    Google Scholar 

  • Cobb, J.C. (1997). Outercourse as a safe and sensible alternative to contraception. American Journal of Public Health, 87, 1380–1381.

    PubMed  CAS  Google Scholar 

  • Cohen, D.A., Farley, T.A., Bedimo-Etame, J.R., Scribner, R., Ward, W., Kendall, C., Rice, J. (1999). Implementation of a condom social marketing program in Louisiana, 1993 to 1996. American Journal of Public Health, 89, 204–208.

    PubMed  CAS  Google Scholar 

  • Dilley, J.W., Woods, W.J., & McFarland, W. (1997). Are advances in treatment changing views about high-risk sex? New England Journal of Medicine, 337, 501–502.

    Article  PubMed  CAS  Google Scholar 

  • Drummond, M.F., Stoddart, G.L., & Torrance, G.W. (1987). Methods for the economic evaluation of health care programmes. New York: Oxford University Press.

    Google Scholar 

  • Edwards, D.M., Shachter, R.D., & Owens, D.K. (1998). A dynamic HIV-transmission model for evaluating the costs and benefits of vaccine programs. Interfaces, 28, 144–166.

    Article  Google Scholar 

  • Elias, C.J. & Coggin, C. (1996). Female-controlled method to prevent sexual transmission of HIV. AIDS, 10 (suppl. 3), S43–S51.

    PubMed  Google Scholar 

  • Fabian, R. (1994). The qualy approach. In G. Tolley, D. Kenkel, & R. Fabian (eds.), Valuing Health for policy: An economic approach. Chicago: University of Chicago Press; 118–136.

    Google Scholar 

  • Farnham, P.G., Gorsky, R.D., Holtgrave, D.R., Jones, W.K., & Guinan, M.E. (1996). Counseling and testing for HIV prevention: costs, effects, and cost effectiveness of more rapid screening tests. Public Health Reports, 111, 44–53.

    PubMed  CAS  Google Scholar 

  • Farr, G., Gabelnick, H., Sturgen, K., & Dorflinger, L. (1994). Contraceptive efficacy and acceptability of the female condom. American Journal of Public Health, 84, 1960–1964.

    PubMed  CAS  Google Scholar 

  • Feldblum, P.J. & Weir, S.S (1994). The protective effect of nonoxynol-9 against HIV infection. American Journal of Public Health, 84, 1032–1034

    PubMed  CAS  Google Scholar 

  • Fiore, J.R., Zhang, Y.J., Björndal, A., Di Stefano, M., Angarano, G., Pastore, G., & Fenyö, E.M. (1997). Biological correlates of HIV-1 heterosexual transmission. AIDS, 11, 1089–1094.

    Article  PubMed  CAS  Google Scholar 

  • France, D. (1999). Emergency treatment to stop AIDS virus. New York Times, October 19.

    Google Scholar 

  • Gerberding, J.L. (1995). Management of occupational exposures to blood-borne viruses. New England Journal of Medicine, 322, 444–451.

    Google Scholar 

  • Gilson, L., Mkanje, R., Grosskurth, H., Mosha, F., Picard, J., Gavyole, A., Todd, J., Mayaud, P., Swai, R., Fransen, L., Mabey, D., Mills, A., & Hayes, R. (1997). Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Lancet, 350, 1805–1809.

    Article  PubMed  CAS  Google Scholar 

  • Gold, M.R., Siegel, J.E., Russell, L.B., & Weinstein, M.C. (Eds.) (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.

    Google Scholar 

  • Gollub, E.L., & Stein, Z.A. (1993). The new female condom-Item 1 on a women’s AIDS prevention agenda. American Journal of Public Health, 83, 498–500.

    PubMed  CAS  Google Scholar 

  • Groseclose, S.L., Weinstein, B., Jones, T.S., Valleroy, L.A. Fehrs, L.J., & Kassler, W.J. (1995). Impact of increased legal access to needles and syringes on the practices of injecting-drug users and police officers—Connecticut, 1992–93. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10, 82–89.

    PubMed  CAS  Google Scholar 

  • Grosskurth, H., Mosha, F., Todd, J., Mwijarubi, E., Klokke, A., & Senkoro, K., Mayaud, P., Changalucha, J., Nicoll, A., ka-Gina, G., Newell, J., Mugeye, K., Mabey, D., & Hayes, R. (1995). Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet, 346, 530–536, 1157–1160.

    Article  PubMed  CAS  Google Scholar 

  • Haddix, A.C. & Shaffer, P.A. (1996). Cost-effectiveness analysis. In A.C. Haddix, S.M. Teutsch, P.A. Shaffer, D.O. Duñet (eds.), Prevention effectiveness: A guide to decision analysis and economic evaluation. New York: Oxford University Press; 103–129.

    Google Scholar 

  • Hardy, A.M., Rausch, K., Echenberg, D., Morgan, W.M., & Curran, J.W. (1986). The economic impact of the first 10,000 cases of acquired immunodeficiency syndrome in the United States. Journal of the American Medical Association, 255, 209–211.

    Article  PubMed  CAS  Google Scholar 

  • Hearst, N. & Hulley, S. B. (1988). Preventing the heterosexual spread of AIDS. Journal of the American Medical Association, 259, 2428–2432.

    Article  PubMed  CAS  Google Scholar 

  • Henderson, D.K. (1991). Postexposure chemoprophylaxis for occupational exposure to human immunodeficiency virus type 1: Current status and prospects for the future. American Journal of Medicine, 91, 322S–319S.

    Article  Google Scholar 

  • Henderson, D.K. & Gerberding, J.L. (1989). Prophylactic zidovudine after occupational exposure to the human immunodeficiency virus: An interim analysis. Journal of Infectious Diseases, 160, 321–327.

    PubMed  CAS  Google Scholar 

  • Hodgson, T.A. (1994). Cost of illness in cost-effectiveness analysis: A review of the methodology. Pharmacoeconomics, 6, 536–552.

    PubMed  CAS  Google Scholar 

  • Holtgrave, D.R. (1994a). Cost analysis and HIV prevention programs. American Psychologist, 49, 1088–1089.

    Article  PubMed  CAS  Google Scholar 

  • Holtgrave, D.R. (1994b). Setting priorities and community planning for HIV-prevention programs. AIDS & Public Policy Journal, 9, 145–150.

    Google Scholar 

  • Holtgrave, D. R. (1997). Public health communication strategies for HIV prevention: past and emerging roles. AIDS, 11 (suppl. A), S183–S190.

    PubMed  Google Scholar 

  • Holtgrave, D.R. (1998). The cost-effectiveness of the components of a comprehensive HIV prevention program: A road map to the literature. In D.R. Holtgrave (ed.), Handbook of economic evaluation of HIV prevention programs. New York: Plenum Press; 127–134.

    Google Scholar 

  • Holtgrave, D.R. & Kelly, J.A. (1996). Preventing HIV/AIDS among high-risk urban women: the cost-effectiveness of a behavioral group intervention. American Journal of Public Health, 86, 1442–1445.

    PubMed  CAS  Google Scholar 

  • Holtgrave, D.R., & Kelly, J.A. (1997). Cost-effectiveness of an HIV/AIDS prevention intervention for gay men. AIDS and Behavior, 1, 173–180.

    Google Scholar 

  • Holtgrave, D.R., Leviton, L.C., Wagstaff, D., & Pinkerton, S.D. (1997). The cumulative probability of HIV infection: A summary risk measure for HIV prevention intervention studies. AIDS and Behavior, 1, 169–172.

    Google Scholar 

  • Holtgrave, D.R. & Pinkerton, S.D. (1997). Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 16, 54–62.

    PubMed  CAS  Google Scholar 

  • Holtgrave, D.R. & Pinkerton, S.D. (1998). The cost-effectiveness of small group and community-level interventions. In D.R. Holtgrave (ed.), Handbook of economic evaluation of HIV prevention programs. New York: Plenum Press; 119–126.

    Google Scholar 

  • Holtgrave, D.R. & Pinkerton, S.D. (in press). The economics of HIV primary prevention. In J.L. Peterson & R.J. DiClemente (eds.), Handbook of HIV prevention. New York: Plenum.

    Google Scholar 

  • Holtgrave, D. R., Pinkerton, S. D., Jones, S., Lurie, P., & Vlahov, D. (1998). Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(suppl. 1), S133–S138.

    PubMed  Google Scholar 

  • Holtgrave, D.R., Qualls, N.L. & Graham, J.D. (1996). Economic evaluation of HIV prevention programs. Annual Review of Public Health, 17, 467–488.

    Article  PubMed  CAS  Google Scholar 

  • Institute of Medicine (1997). The hidden epidemic: Confronting sexually transmitted diseases. Washington DC: National Academy Press.

    Google Scholar 

  • Jacquez, J.A., Koopman, J.S., Simon, C.P., & Longini, I.M. (1994). Role of the primary infection in epidemic of HIV infection in gay cohorts. Journal of Acquired Immune Deficiency Syndromes, 7, 1169–1184.

    PubMed  CAS  Google Scholar 

  • Johnson-Masotti, A.P., Pinkerton, S.D., Kelly, J.A., & Stevenson, L.Y. (in press). Cost-effectiveness of an HIV risk reduction intervention for adults with severe mental illness. AIDS Care.

    Google Scholar 

  • Kahn, J.G. & Haynes-Sanstad, K.C. (1997). The role of cost-effectiveness analysis in assessing HIV-prevention interventions. AIDS & Public Policy Journal, 12, 21–30.

    CAS  Google Scholar 

  • Kahn, J.G., Kegeles, S.M., Hays, R., & Beltzer, N. (under review). The cost-effectiveness of the Mpowerment Project, a community-level intervention for young gay men.

    Google Scholar 

  • Kalichman, S.C., Nachimson, D., Cherry, C., & Williams, E. (1998). AIDS treatment advances and behavioral prevention setbacks: preliminary assessment of reduced perceived threat of HIV-AIDS. Health Psychology, 17, 546–550.

    PubMed  CAS  Google Scholar 

  • Katz, M.H. & Gerberding, J.L. (1997). Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use. New England Medical Journal, 336, 1098–1100.

    Google Scholar 

  • Katz, M.H. & Gerberding, J.L. (1998). The care of persons with recent sexual exposure to HIV. Annals of Internal Medicine, 128, 306–312.

    PubMed  CAS  Google Scholar 

  • Kelly, J.A., Otto-Salaj, L.L., Sikkema, K.J., Pinkerton, S.D., & Bloom, F.R. (1998). Implications of HIV treatment advances for behavioral research on AIDS: Protease inhibitors and new challenges in HIV secondary prevention. Health Psychology, 17, 310–319.

    PubMed  CAS  Google Scholar 

  • Kippax, S., Noble, J., Prestage, G., Crawford, J.M., Campbell, D., Baxter, D., & Cooper, D. (1997). Sexual negotiation in the AIDS era: Negotiated safety revisited. AIDS, 11, 191–197.

    Article  PubMed  CAS  Google Scholar 

  • Kippax, S., Crawford, J., Davis, M., Rodden, P., & Dowsett, G. (1993). Sustaining safe sex: a longitudinal study of a sample of homosexual men. AIDS, 7, 257–263.

    PubMed  CAS  Google Scholar 

  • Kreiss, J., Ngugi, E., Holmes, K., Ndinya-Achola, J., Waiyaki, P., Roberts, P.L., et al. (1992). Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. Journal of the American Medical Association, 268, 477–482.

    Article  PubMed  CAS  Google Scholar 

  • Lee, T-H, Sakahara, N., Fiebig, E., Busch, M.P., O’Brien, T.R., & Herman, S.A. (1996). Correlation of HIV-1 RNA levels in plasma and heterosexual transmission of HIV-1 from infected transfusion recipients. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 12, 427–428.

    PubMed  CAS  Google Scholar 

  • Lurie, P., Gorsky, R., Jones, S., & Shomphe, L. (1998). An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(suppl. 1), S126–S132.

    PubMed  Google Scholar 

  • Mastro, T.D. & de Vincenzi, I. (1996). Probabilities of sexual HIV-1 transmission. AIDS, 10 (suppl. A), S75–S82.

    PubMed  Google Scholar 

  • Murphy, S.T., Miller, L.C., Appleby, P.R., Marks, G. & Mansergh, G. (1999). Antiretroviral drugs and sexual behavior in gay and bisexual men: When optimism enhances risk. Presented at the 1999 National HIV Prevention Conference, Atlanta, August 29–September 1, 1999.

    Google Scholar 

  • Moses, S., Plummer, F.A., Ngugi, E.N., Nagelkerke, N.J.D., Anzala, A.O., & Ndinya-Achola, J.O. (1991). Controlling HIV in Africa: effectiveness and cost of an intervention in a high-frequency STD transmitter core group. AIDS, 5, 407–411.

    PubMed  CAS  Google Scholar 

  • Murphy, J.S. (1990). The condom industry in the United States. Jefferson, NC: McFarland.

    Google Scholar 

  • Musicco, M., Lazzarin, A., Nicolosi, A., Gasparini, M., Costigliola, P., Arici, C., & Saracco, A. (1994). Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Archives of Internal Medicine, 154, 1971–1976.

    Article  PubMed  CAS  Google Scholar 

  • Operskalski, E.A., Stram, D.O., Busch, M.P., Huang, W., Harris, M., Dietrich, S.L., Schiff, E.R., Donegan, E., & Mosley, J.W. (1997). Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. American Journal of Epidemiology, 146, 655–661.

    PubMed  CAS  Google Scholar 

  • Over, M., Bertozzi, S., Chin, J., N’galy, B., & Nyamuryekung’e, K. (1988). The direct and indirect costs of HIV infections in developing countries: The cases of Zaire and Tanzania. In A.F. Fleming, D.W. Fitzsimons, J. Mann, M. Carballo, & M.R. Bailey (eds.), The global impact of AIDS. New York: Alan R. Liss; 123–135.

    Google Scholar 

  • Paltiel, A.D. & Stinnett, A.A. (1998). Resource allocation and the funding of HIV prevention. In D.R. Holtgrave (ed.), Handbook of economic evaluation of HIV prevention programs. New York: Plenum; 135–152.

    Google Scholar 

  • Pinkerton, S.D. (in press). A relative risk-based, disease-specific definition of sexual abstinence failure rates. Health Education and Behavior.

    Google Scholar 

  • Pinkerton, S.D. & Abramson, P.R. (1992). Is risky sex rational? The Journal of Sex Research, 29, 561–568.

    Google Scholar 

  • Pinkerton, S.D. & Abramson, P.R. (1993a). Evaluating the risks: A Bernoulli process model of HIV infection and risk reduction. Evaluation Review, 17, 504–528.

    Google Scholar 

  • Pinkerton, S.D. & Abramson, P.R. (1993b). HIV vaccines: A magic bullet in the fight against AIDS? Evaluation Review, 17, 579–602.

    Google Scholar 

  • Pinkerton, S.D. & Abramson, P.R. (1995). The joys of diversification: Vaccines, condoms, and AIDS prevention. AIDS & Public Policy Journal, 10, 148–156.

    Google Scholar 

  • Pinkerton, S.D. & Abramson, P.R. (1996a). Occasional condom use and HIV risk reduction. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 13, 456–460.

    PubMed  CAS  Google Scholar 

  • Pinkerton, S.D. & Abramson, P.R. (1996b). Implications of increased infectivity in early-stage HIV infection: Application of a Bernoulli-process model of HIV transmission. Evaluation Review, 20, 516–540.

    PubMed  CAS  Google Scholar 

  • Pinkerton, S.D. & Abramson, P.R. (1997). Effectiveness of condoms in preventing HIV transmission. Social Science & Medicine, 44, 1303–1312.

    Article  CAS  Google Scholar 

  • Pinkerton, S.D. & Abramson, P.R. (1998). The Bernoulli-process model of HIV transmission: Applications and implications. In D.R. Holtgrave (ed.), Handbook of economic evaluation of HIV prevention programs. New York: Plenum Press; 13–32.

    Google Scholar 

  • Pinkerton, S.D., Abramson, P.R., & Holtgrave, D.R. (1999). What is a condom worth? AIDS and Behavior, 3, 301–312.

    Article  Google Scholar 

  • Pinkerton, S.D. & Holtgrave, D.R. (1998a). Assessing the cost-effectiveness of HIV prevention interventions: A primer. In D.R. Holtgrave (ed.), Handbook of economic evaluation of HIV prevention programs. New York: Plenum Press; 33–43.

    Google Scholar 

  • Pinkerton, S.D. & Holtgrave, D.R. (1998b). A method for evaluating the economic efficiency of HIV behavioral risk reduction interventions. AIDS and Behavior, 2, 189–201.

    Article  Google Scholar 

  • Pinkerton, S.D. & Holtgrave, D.R. (1999a). Economic impact of delaying or preventing AIDS in persons with HIV. American Journal of Managed Care, 5, 289–298.

    PubMed  CAS  Google Scholar 

  • Pinkerton, S.D. & Holtgrave, D.R. (1999b). Combination antiretroviral therapies for HIV: Some economic considerations. In D.G. Ostrow & S.C. Kalichman (eds.), Psychosocial and public health impacts of New HIV therapies. New York: Kluwer Academic/Plenum; 83–112.

    Google Scholar 

  • Pinkerton, S.D., Holtgrave, D.R., & Bloom, F.R. (1997). Postexposure treatment of HIV. New England Journal of Medicine, 337, 500–501.

    PubMed  CAS  Google Scholar 

  • Pinkerton, S.D., Holtgrave, D.R., & Bloom, F.R. (1998). Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV. AIDS, 12, 1067–1078.

    Article  PubMed  CAS  Google Scholar 

  • Pinkerton, S.D., Holtgrave, D.R., DiFranceisco, W.J., Stevenson, L.Y., & Kelly, J.A. (1998a). Cost-effectiveness of a community-level HIV risk reduction intervention. American Journal of Public Health, 88, 1239–1242.

    PubMed  CAS  Google Scholar 

  • Pinkerton, S.D., Holtgrave, D.R., DiFranceisco, W.J., Stevenson, L.Y., & Kelly, J.A. (1998b). Cost-effectiveness of a community-level HIV prevention intervention research trial. In D.R. Holtgrave (ed.), Handbook of economic evaluation of HIV prevention programs. New York: Plenum Press; 243–259.

    Google Scholar 

  • Pinkerton, S.D., Holtgrave, D.R., DiFranceisco, W., Semaan, S., & Coyle, S.L. (under review). Cost-threshold analyses of the National AIDS Demonstration Research (NADR) HIV prevention interventions. AIDS.

    Google Scholar 

  • Pinkerton, S.D., Holtgrave, D.R., & Jemmott, J.B. (under review). Economic analysis of an HIV risk reduction intervention for male African American adolescents. Journal of Acquired Immune Deficiency Syndromes.

    Google Scholar 

  • Pinkerton, S.D., Holtgrave, D.R., Leviton, L.C., Wagstaff, D.A., & Abramson, P.R. (1998). Model-based evaluation of HIV prevention interventions. Evaluation Review, 22, 155–174.

    PubMed  CAS  Google Scholar 

  • Pinkerton, S.D., Holtgrave, D.R., Leviton, L.C., Wagstaff, D.A., Cecil, H., & Abramson, P.R. (1998). Toward a standard sexual behavior data set for HIV prevention evaluation. American Journal of Health Behavior, 22, 259–266.

    Google Scholar 

  • Pinkerton, S.D., Holtgrave, D.R., & Valdiserri, R.O. (1997). Cost-effectiveness of HIV prevention skills training for men who have sex with men. AIDS, 11, 347–357.

    Article  PubMed  CAS  Google Scholar 

  • Pinkerton, S.D., Holtgrave, D.R., Willingham, M., & Goldstein, E. (1998). Cost-effectiveness analysis and HIV prevention community planning. AIDS & Public Policy Journal, 13, 115–127.

    CAS  Google Scholar 

  • Pinkerton, S.D., Kahn, J.G., & Holtgrave, D.R. (under review). The cost-effectiveness of community-level approaches to HIV prevention: A review. Journal of Primary Prevention.

    Google Scholar 

  • Potts, M. (1994). The urgent need for a vaginal microbicide in the prevention of HIV transmission. American Journal of Public Health, 84, 890–891.

    PubMed  CAS  Google Scholar 

  • Ragni, M.V., Faruki, H., & Kingsley, L.A. (1998). Heterosexual HIV-1 transmission and viral load in hemophilic patients. Journal of Acquired Immune Deficiency Syndromes, 17, 42–45.

    CAS  Google Scholar 

  • Rehle, T.M., Saidel, T.J., Hassig, S.E., Bouey, P.D., Gaillard, E.M., & Sokal, D.C. (1998). AVERT: a user-friendly model to estimate the impact of HIV/sexually transmitted disease prevention interventions on HIV transmission. AIDS, 12(suppl. 2), S27–S35.

    PubMed  Google Scholar 

  • Reiss, I.L. and Leik, R.K. (1989). Evaluating strategies to avoid AIDS: Number of partners vs. use of condoms. Journal of Sex Research, 26, 411–433.

    Article  Google Scholar 

  • Rice, D.P. (1967). Estimating the cost of illness. American Journal of Public Health, 57, 424–440.

    CAS  PubMed  Google Scholar 

  • Rice, D.P. and Max, W. (1996). Appendix I: Productivity loss tables. In A.C. Haddix, S.M. Teutsch, P.A. Shaffer, and D.O. Duñet (Eds.), Prevention effectiveness: A guide to decision analysis and economic evaluation. New York: Oxford University Press; 187–192.

    Google Scholar 

  • Ridge, D.T., Plummer, D.C., & Minichiello, V. (1994). Knowledge and practice of sexual safety in Melbourne gay men in the nineties. Australian Journal of Public Health, 18, 319–325.

    PubMed  CAS  Google Scholar 

  • Roddy, R.E., Schulz, F.F. Cates, W. Jr. (1998). Microbicides, meta-analysis, and the N-9 question: Where’s the research? Sexually Transmitted Diseases, 25, 151–153.

    PubMed  CAS  Google Scholar 

  • Roddy, R.E., Zekeng, L., Ryan, K.A., Tamoufé, U., Weir, S.S., & Wong, E.L. (1998). A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. New England Journal of Medicine, 339, 504–510.

    Article  PubMed  CAS  Google Scholar 

  • Scitovsky, A.A. & Rice, D.P. (1987). Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991. Public Health Reports, 102, 5–17.

    PubMed  CAS  Google Scholar 

  • Schrappe, M. & Lauterbach, K. (1998). Systematic review on the cost-effectiveness of public health interventions for HIV prevention in industrialized countries. AIDS, 12(suppl. A), S231–S238.

    PubMed  Google Scholar 

  • Söderlund, N., Lavis, J., Broomberg, J., & Mills, A. (1993). The costs of HIV prevention strategies in developing countries. Bulletin of the World Health Organization, 71, 595–604.

    PubMed  Google Scholar 

  • Stein, Z.A. (1990). HIV prevention: the need for methods women can use. American Journal of Public Health, 80, 460–462.

    PubMed  CAS  Google Scholar 

  • Stein, Z.A. (1993). HIV prevention: an update on the status of methods women can use. American Journal of Public Health, 83, 1379–1382.

    PubMed  CAS  Google Scholar 

  • Stein, Z.A. (1995). More on women and the prevention of HIV infection. American Journal of Public Health, 85, 1485–1488.

    PubMed  CAS  Google Scholar 

  • Stephenson, J. (1999). Report offers vision for microbicide development. Journal of American Medical Association, 281, 405.

    CAS  Google Scholar 

  • Stockbridge, E.L., Gollub, E., Stein, Z., & El-Sadr, W. (1996). Power and the female condom. Family Planning Perspectives, 28, 78–79.

    PubMed  CAS  Google Scholar 

  • Sweat, M.D. & Denison, J. (1998). Changing public policy to prevent HIV transmission: The role of structural and environmental interventions. In D.R. Holtgrave (ed.), Handbook of economic evaluation of HIV prevention programs. New York: Plenum Press; 103–117.

    Google Scholar 

  • Tao, G. & Remafedi, G. (1997). Economic evaluation of an HIV prevention intervention for gay and bisexual male adolescents. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 17, 83–90.

    Google Scholar 

  • Trussell, J., Leveque, J.A., Koenig, J.D., London, R., Borden, S., Henneberry, J., LaGuardia, K.D., Stewart, F., Wilson, G., Wysocki, S., & Strauss, M. (1995). The economic value of contraception: A comparison of 15 methods. American Journal of Public Health, 85, 494–503.

    Article  PubMed  CAS  Google Scholar 

  • Trussell, J., Sturgen, K., Strickler, J., & Dominik, R. (1994). Comparative contraceptive efficacy of the female condom and other barrier methods. Family Planning Perspectives, 26, 66–72.

    PubMed  CAS  Google Scholar 

  • Valdiserri, R.O., Aultman, T.V., & Curran, J.W. (1995). Community planning: A national strategy to improve HIV prevention programs. Journal of Community Health, 20, 87–100.

    Article  PubMed  CAS  Google Scholar 

  • Valleroy, L.A., Weinstein, B., Jones, T.S., Groseclose, S.L., Rolfs, R.T., & Kassler, W.J. (1995). Impact of increased legal access to needles and syringes on community pharmacies’ needle and syringe sales—Connecticut, 1992–1993. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10, 73–81.

    PubMed  CAS  Google Scholar 

  • Vlahov, D. (1995). Deregulation of the sale and possession of syringes for HIV prevention among injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10, 71–72.

    PubMed  CAS  Google Scholar 

  • World Bank (1997). Confronting AIDS: Public priorities in a global epidemic. London: Oxford University Press.

    Google Scholar 

  • Wright-De Agüero, L., Weinstein, B., Jones, T.S., & Miles, J. (1998). Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers’ practice. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(suppl 1), S102–110.

    Google Scholar 

  • Young, B. (1997). The need for methods women can control for preventing HIV infection and other sexually transmitted diseases. California HIV/AIDS Update, 10(4).

    Google Scholar 

  • Zhu, T., Wang, N., Carr, A., Nam, D.S., Moor-Jankowski, R., Cooper, D.A., & Ho, D.D. (1996). Genetic characterization of human immunodeficiency virus type 1 in blood and genetic secretions: Evidence for viral compartmentalization and selection during sexual transmission. Journal of Virology, 70, 3098–3107.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for AIDS Intervention Research Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Wisconsin, USA

    Steven D. Pinkerton

  2. Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia

    David R. Holtgrave

Authors
  1. Steven D. Pinkerton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David R. Holtgrave
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Centers for Disease Control and Prevention, Atlanta, Georgia

    Ann O’Leary

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Pinkerton, S.D., Holtgrave, D.R. (2002). Assessing the Cost-effectiveness of Alternative Approaches to HIV Prevention. In: O’Leary, A. (eds) Beyond Condoms. Springer, Boston, MA. https://doi.org/10.1007/0-306-47518-9_7

Download citation

  • DOI: https://doi.org/10.1007/0-306-47518-9_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46731-8

  • Online ISBN: 978-0-306-47518-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation